PREIMPLANTATION EMBRYO DIAGNOSIS-FROM INVASIVE TROPHOBLAST BIOPSY TO ANALYSIS OF CELL-FREE DNA IN CULTURE MEDIUM
Authors:
- Ewa BełcEBEwa Bełc
- Rafał BoreckiRBRafał Borecki
- Klaudia JurkowskaKJKlaudia Jurkowska
- Martyna StanikMSMartyna Stanik
- Joanna GórakJGJoanna Górak
- Eleonora Y. MahoneyEMEleonora Y. Mahoney
- Agata ReliszkaARAgata Reliszka
- Aleksandra StadnikASAleksandra Stadnik
- Adrianna KęPaAKAdrianna KęPa
- Elżbieta TrzynaETElżbieta Trzyna
Open Access
- 19 June 2026
- journal article
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 3 (2(50))
Abstract
Background: Infertility is a global socio-demographic crisis, affecting approximately 17.5% of the population. Although in vitro fertilization is the therapeutic gold standard, the phenotype-genotype dichotomy reveals that morphologically ideal embryos often harbor genetic abnormalities, leading to implantation failure and miscarriages. Objective: This review examines the transition from invasive methods to non-invasive preimplantation genetic testing (niPGT), evaluating cell-free DNA (cfDNA) analysis in culture media, integrated with artificial intelligence (AI), and time-lapse imaging. This synergy aims to optimize embryo selection and improve clinical outcomes in assisted reproductive medicine. Methods: A comprehensive review of literature from PubMed and Google Scholar was conducted. The analysis focused on the mechanisms of cfDNA release, concordance rates between niPGT and trophectoderm biopsy, and the implementation of deep learning algorithms in morphokinetic assessment. Results: NiPGT offers significant potential for providing a comprehensive genetic profile of the embryo, potentially eliminating mosaicism limitations inherent in traditional biopsies. Current results indicate concordance rates of 65-90% compared to invasive PGT. The integration of AI databases and Vision Transformer models enhances diagnostic accuracy by correlating molecular data with dynamic developmental patterns. However, challenges such as maternal DNA contamination and the lack of global standardization remain key barriers to widespread implementation. Conclusion: NiPGT marks a new era in personalized reproductive medicine, prioritizing embryo safety and biological integrity. While currently a selection-support tool rather than a full replacement for invasive methods, its synergy with AI offers a safer, more effective path toward the gold standard- the birth of a single healthy child.Keywords
This publication has 42 references indexed in Scilit:
- Validation of non-invasive preimplantation genetic testing for aneuploidies (niPGT-A) in a Japanese population: experience from seven clinicsJournal of Assisted Reproduction and Genetics, 2025
- Global, regional, and national burden of infertility, 1990–2021: systematic analysis of the Global Burden of Disease Study 2021Journal of Assisted Reproduction and Genetics, 2025
- Optimizing Non‐Invasive PGT ‐A: A Multi‐Factorial Approach for Enhanced Accuracy and Seamless Integration Into Clinical IVFReproductive Medicine and Biology, 2025
- Preimplantation genetic testing for structural rearrangements by genome-wide SNP genotyping and haplotype analysis: a prospective multicenter clinical studyEBioMedicine, 2024
- Optimizing non-invasive preimplantation genetic testing: investigating culture conditions, sample collection, and IVF treatment for improved non-invasive PGT-A resultsJournal of Assisted Reproduction and Genetics, 2024
- Artificial intelligence in time-lapse system: advances, applications, and future perspectives in reproductive medicineJournal of Assisted Reproduction and Genetics, 2023
- New frontiers in embryo selectionJournal of Assisted Reproduction and Genetics, 2023
- European Association of Urology Guidelines on Male Sexual and Reproductive Health: 2021 Update on Male InfertilityEuropean Urology, 2021
- Preimplantation genetic testing for aneuploidy versus morphology as selection criteria for single frozen-thawed embryo transfer in good-prognosis patients: a multicenter randomized clinical trialFertility and Sterility, 2019
- A prospective study of non-invasive preimplantation genetic testing for aneuploidies (NiPGT-A) using next-generation sequencing (NGS) on spent culture media (SCM)Journal of Assisted Reproduction and Genetics, 2019